Aortic valve interventions

Antithrombotic therapy in TAVI patients: changing concepts

EuroIntervention 2015;11:W92-W95. DOI: 10.4244/EIJV11SWA28

Giuseppe Gargiulo
Giuseppe Gargiulo1, MD; Jean-Philippe Collet2, MD; Marco Valgimigli1*, MD, PhD
1. Department of Cardiology, Bern University Hospital, Bern, Switzerland; 2. ACTION Study Group, Institut de Cardiologie, Centre Hospitalier Universitaire Pitié-Salpêtriėre (AP-HP), Université Paris 6, Paris, France

The clinical and demographic characteristics of patients undergoing TAVI pose unique challenges for developing and implementing optimal antithrombotic therapy. Ischaemic and bleeding events in the periprocedural period and mo

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

anticoagulantantiplateletantithrombotic therapytranscatheter aortic valve implantation (tavi)
Interventions for valvular diseaseTAVIAdjunctive pharmacotherapy
Read next article
TAVI and concomitant procedures: from PCI to LAA closure

Latest news